Estrogen biosynthesis in endometriosis: Molecular basis and clinical relevance

Journal of Molecular Endocrinology

Volumn 25, Issue 1, 2000, Pages 35-42

  Bulun, S E ^a   Zeitoun, K M ^a   Takayama, K ^a   Sasano, H ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; AROMATASE INHIBITOR; ESTRADIOL; ESTRONE; TESTOSTERONE 17BETA DEHYDROGENASE;

DRUG MECHANISM; ENDOMETRIOSIS; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEROIDOGENESIS;

EID: 0033856511     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0250035     Document Type: Review

References (31)

1. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture
2. Physiology and molecular genetics of 17β-hydroxysteroid dehydrogenases
3. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice
4. Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua
5. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription
6. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human lelomyoma tissues and cells in culture
7. Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro
8. Administration of nasal nafarelin as compared with oral danazol for endometriosis
9. Immunology and endometriosis
10. Regulation of cyclooxygenase-2 gene in cultured endometrial stromal cells by sex steroids. Proceedings of the American Society of Reproductive Medicine Meeting S5 (abstract)
11. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis
12. Chronic gynecological conditions reported by US women: Findings from the National Health Information Survey 1984 to 1992
13. 4-androstenedione to estrone in normal males and non-pregnant normal, castrate and adrenalectomized females
14. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer
15. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: Correlation with histology and steroid receptor content
16. Ad4 BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary
17. A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene
18. Aromatase expression in endometriosis
19. 2 stimulates aromatase expression in endometriosis-derived stromal cells
20. Endometriosis
21. Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis
22. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity
23. Distribution of progesterone receptor, estradiol dehydrogenase, and 20α-dihydroprogesterone dehydrogenase activities in human endometrial glands and stroma: Progestin induction of steroid dehydrogenase activities in vitro is restricted to the glandular epithelium
24. Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveals homology with tissue inhibitor of metalloproteinases-1 (TIMP-1)
25. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis
26. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor
27. Epidemiology of endometriosis in women attending family planning clinics
28. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: Long-term follow-up
29. Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: Failure to metabolize estradiol-17β
30. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of SF-1 and COUP-TF to the same cis-acting element